Madrigal Pharmaceuticals Inc (MDGL) — Working Capital to Net Assets Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Working Capital to Net Assets ratio of 155.2% as of December 2025. Working capital of $935.48 Million (current assets of $1.25 Billion minus current liabilities of $310.29 Million) is measured against net assets of $602.69 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Madrigal Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Madrigal Pharmaceuticals Inc Working Capital to Net Assets (2003–2025)
This chart shows how Madrigal Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of December 2025, the ratio stands at 155.2%, reflecting working capital of $935.48 Million against net assets of $602.69 Million USD. See MDGL days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Madrigal Pharmaceuticals Inc (2003–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Madrigal Pharmaceuticals Inc from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Madrigal Pharmaceuticals Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 155.2% | $935.48 Million | $602.69 Million | $1.25 Billion | $310.29 Million | ▲ +40.7 pp |
| 2024 | 114.5% | $863.65 Million | $754.38 Million | $1.03 Billion | $169.28 Million | ▼ -13.5 pp |
| 2023 | 128.0% | $518.73 Million | $405.33 Million | $637.28 Million | $118.55 Million | ▲ +3.6 pp |
| 2022 | 124.4% | $245.47 Million | $197.39 Million | $361.37 Million | $115.89 Million | ▲ +25.0 pp |
| 2021 | 99.4% | $194.85 Million | $196.11 Million | $271.68 Million | $76.84 Million | ▼ -0.1 pp |
| 2020 | 99.4% | $238.61 Million | $239.97 Million | $285.16 Million | $46.56 Million | ▼ -0.2 pp |
| 2019 | 99.6% | $415.07 Million | $416.56 Million | $440.20 Million | $25.13 Million | ▼ -0.3 pp |
| 2018 | 100.0% | $476.76 Million | $476.98 Million | $485.20 Million | $8.44 Million | ▲ +0.1 pp |
| 2017 | 99.8% | $181.96 Million | $182.26 Million | $192.01 Million | $10.05 Million | ▼ -0.2 pp |
| 2016 | 100.0% | $36.41 Million | $36.41 Million | $41.21 Million | $4.80 Million | ▲ +197.0 pp |
| 2015 | -97.0% | $-48.91 Million | $50.41 Million | $363.58K | $49.28 Million | ▼ -202.1 pp |
| 2014 | 105.1% | $68.46 Million | $65.14 Million | $99.35 Million | $30.89 Million | ▼ -17.2 pp |
| 2013 | 122.3% | $60.03 Million | $49.09 Million | $92.24 Million | $32.21 Million | ▲ +18.5 pp |
| 2012 | 103.8% | $77.90 Million | $75.07 Million | $101.39 Million | $23.49 Million | ▼ -66.4 pp |
| 2011 | 170.2% | $25.14 Million | $14.77 Million | $40.29 Million | $15.15 Million | ▲ +22.0 pp |
| 2010 | 148.1% | $34.78 Million | $23.48 Million | $51.52 Million | $16.74 Million | ▲ +35.3 pp |
| 2009 | 112.8% | $28.11 Million | $24.91 Million | $44.57 Million | $16.47 Million | ▲ +211.3 pp |
| 2008 | -98.5% | $57.90 Million | $-58.79 Million | $91.22 Million | $33.32 Million | ▼ -485.0 pp |
| 2007 | 386.5% | $96.22 Million | $24.90 Million | $117.00 Million | $20.77 Million | ▲ +2451.8 pp |
| 2006 | -2065.3% | $36.08 Million | $-1.75 Million | $47.63 Million | $11.55 Million | ▼ -2157.7 pp |
| 2005 | 92.4% | $48.48 Million | $52.48 Million | $62.95 Million | $14.47 Million | ▼ -3.5 pp |
| 2004 | 95.9% | $113.15 Million | $117.96 Million | $126.02 Million | $12.88 Million | ▲ +0.2 pp |
| 2003 | 95.7% | $73.56 Million | $76.89 Million | $77.06 Million | $3.50 Million | — |